0001062993-17-005233.txt : 20171212 0001062993-17-005233.hdr.sgml : 20171212 20171212155529 ACCESSION NUMBER: 0001062993-17-005233 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171212 DATE AS OF CHANGE: 20171212 EFFECTIVENESS DATE: 20171212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trillium Therapeutics Inc. CENTRAL INDEX KEY: 0001616212 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1214 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-300546 FILM NUMBER: 171251770 BUSINESS ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 BUSINESS PHONE: (416) 595-0627 MAIL ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 D 1 primary_doc.xml X0708 D LIVE 0001616212 Trillium Therapeutics Inc. 2488 DUNWIN DRIVE MISSISSAUGA A6 ONTARIO, CANADA L5L 1J9 (416) 595-0627 ONTARIO, CANADA Stem Cell Therapeutics Corp. Neurogenesis Biotech Corp. None Corporation true Luke Beshar 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Henry Frieson 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Michael Moore 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Calvin Stiller 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Niclas Stiernholm 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Director James Parsons 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Penka Petrova 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Eric Sievers 2488 Dunwin Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Helen Tayton-Martin 2488 Dunwin Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Robert Kirkman 2488 Dunwin Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Thomas Reynolds 2488 Dunwin Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Robert Uger 2488 Dunwin Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-12-01 false true false 0 Cowen and Company, LLC 7616 None None 599 Lexington Avenue 20th Floor NEW YORK NY NEW YORK 10022 All States false 19975000 19975000 0 false 2 1198500 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees, including executives. false Trillium Therapeutics Inc. /s/ James Parsons James Parsons CFO 2017-12-12